The Centers for Medicare and Medicaid Services and NCI said they are developing a Memorandum of Understanding to address how the agencies can work together to improve the process for making coverage decisions for cancer therapy and diagnosis.
Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.
Access to mammography needs improvement, IOM National Cancer Policy Board report finds.
NCAB, President’s Cancer Panel honor the late Paul Calabresi.
Funding opportunities listed.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Galleri MCD vote: What FDA asked its advisors to ignore
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
